Safety and Efficacy of Bone Marrow Derived Autologous Cells Treatment of Cerebral Palsy in Subjects Above 15 Years

Inclusion Criteria: * Subject aged above 15 years with a diagnosis of Cerebral Palsy. Regional Nerve damage as shown by Magnetic Resonance Imaging(MRI) * Patient suffer from cerebral palsy due to prenatal and postnatal cause, * Willing to undergoing Bone Marrow derived autologous stem cell therapy. * Able to Comprehend and give written informed consent form for the study * willing to come to the hospital for follow up visits as per the protocol requirements Exclusion Criteria: * History of meningitis,meningoencephalitis , epilepsy or life threatening allergic or immune -mediated reaction * Hemodynamically unstable patients * history of or concurrent autoimmune disease or acute episode if Guillain- barre syndrome * peripheral Muscular dystrophy